Tango Therapeutics Inc (TNGX)

R&D Expenses

$134.37M

TTM · Period ending: · USD

TNGX logo

TNGX R&D Expenses

Latest reported$134.37M
TNGX TTM R&D Expenses ($49.99M → $134.37M)
High-resolution chart · PNG

TNGX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tango Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
134,365,999
129,348,999
132,720,000
133,376,000
135,824,000
142,296,000
143,919,000
141,321,000
135,207,000
125,224,000
115,198,000
112,950,000
114,545,000
109,615,000
105,906,000
98,449,000
91,628,000
86,966,000
77,636,000
71,065,000
62,119,000
54,169,000
49,991,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.